iBio, Inc.
IBIO
$1.25
-$0.02-1.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -105.33% | -59.02% | -106.07% | -43.39% | 33.62% |
| Total Depreciation and Amortization | -12.28% | -11.35% | -14.23% | 3.96% | 1.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 84.71% | 683.43% | 489.80% | -25.51% | -94.79% |
| Change in Net Operating Assets | 45,550.00% | -224.60% | 420.65% | -32.25% | 100.36% |
| Cash from Operations | -34.95% | -95.94% | -35.46% | -52.49% | 4.92% |
| Capital Expenditure | -1,800.00% | 21.43% | -51,500.00% | -- | 99.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9,650.00% | -- | -246,600.00% | -3,109.96% | -- |
| Cash from Investing | -9,904.44% | -22,121.43% | -149,050.00% | -3,114.45% | 131.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | -261.18% | 3.61% | 85.23% |
| Issuance of Common Stock | 957.49% | 507.67% | 20,183.33% | 8,000.00% | -83.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -202.35% | -- | -- | -- | 6,863.64% |
| Cash from Financing | 137.21% | 2,548.54% | 5,879.61% | 28,930.25% | -37.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.77% | 1,022.13% | 113.94% | 717.79% | -54.84% |